(-)-demecolcine decreases expression ISO CDKN2C (Homo sapiens) 6480464 Demecolcine results in decreased expression of CDKN2C mRNA CTD PMID:23649840 (1->4)-beta-D-glucan multiple interactions ISO Cdkn2c (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CDKN2C mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO Cdkn2c (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of CDKN2C mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO Cdkn2c (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CDKN2C mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CDKN2C mRNA CTD PMID:17351261 17beta-estradiol decreases expression ISO CDKN2C (Homo sapiens) 6480464 Estradiol results in decreased expression of CDKN2C mRNA CTD PMID:16474171 more ... 17beta-estradiol multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CDKN2C mRNA CTD PMID:26496021 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO CDKN2C (Homo sapiens) 6480464 2 more ... CTD PMID:26988655 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cdkn2c (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CDKN2C mRNA CTD PMID:15667827 and PMID:21354282 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CDKN2C mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cdkn2c (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CDKN2C mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CDKN2C mRNA CTD PMID:22298810 and PMID:34747641 2-acetamidofluorene increases expression EXP 6480464 2-Acetylaminofluorene results in increased expression of CDKN2C mRNA CTD PMID:22584684 2-hydroxypropanoic acid decreases expression ISO CDKN2C (Homo sapiens) 6480464 Lactic Acid results in decreased expression of CDKN2C mRNA CTD PMID:30851411 4,4'-sulfonyldiphenol increases expression ISO Cdkn2c (Mus musculus) 6480464 bisphenol S results in increased expression of CDKN2C mRNA CTD PMID:30951980 5-fluorouracil decreases expression ISO CDKN2C (Homo sapiens) 6480464 Fluorouracil results in decreased expression of CDKN2C mRNA CTD PMID:16557594 acetamide increases expression EXP 6480464 acetamide results in increased expression of CDKN2C mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO Cdkn2c (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of CDKN2C mRNA CTD PMID:19770486 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CDKN2C mRNA CTD PMID:23630614 and PMID:25378103 all-trans-retinoic acid increases expression ISO CDKN2C (Homo sapiens) 6480464 Tretinoin results in increased expression of CDKN2C mRNA CTD PMID:16140955 and PMID:23724009 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of CDKN2C mRNA CTD PMID:18355885 amitriptyline affects expression EXP 6480464 Amitriptyline affects the expression of CDKN2C mRNA CTD PMID:18355885 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CDKN2C mRNA CTD PMID:16483693 apigenin increases expression ISO CDKN2C (Homo sapiens) 6480464 Apigenin results in increased expression of CDKN2C mRNA CTD PMID:18331776 arsenite(3-) decreases expression ISO Cdkn2c (Mus musculus) 6480464 arsenite results in decreased expression of CDKN2C mRNA CTD PMID:18929588 arsenite(3-) multiple interactions ISO CDKN2C (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to CDKN2C mRNA] CTD PMID:32406909 arsenous acid increases expression ISO CDKN2C (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of CDKN2C mRNA CTD PMID:17530438 and PMID:20862710 arsenous acid decreases expression ISO CDKN2C (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of CDKN2C mRNA CTD PMID:26705709 auraptene affects expression ISO CDKN2C (Homo sapiens) 6480464 aurapten affects the expression of CDKN2C mRNA CTD PMID:23320178 benzo[a]pyrene increases expression ISO Cdkn2c (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CDKN2C mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO CDKN2C (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CDKN2C promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO CDKN2C (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of CDKN2C mRNA CTD PMID:21632981 and PMID:26238291 benzo[a]pyrene multiple interactions ISO Cdkn2c (Mus musculus) 6480464 [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of CDKN2C mRNA CTD PMID:25820237 benzo[a]pyrene decreases expression ISO Cdkn2c (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of CDKN2C mRNA CTD PMID:21569818 benzo[a]pyrene diol epoxide I decreases expression ISO CDKN2C (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 benzo[b]fluoranthene increases expression ISO Cdkn2c (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of CDKN2C mRNA CTD PMID:26377693 Benzo[ghi]perylene decreases expression ISO Cdkn2c (Mus musculus) 6480464 1 and 12-benzoperylene results in decreased expression of CDKN2C mRNA CTD PMID:26377693 bicalutamide decreases expression ISO CDKN2C (Homo sapiens) 6480464 bicalutamide results in decreased expression of CDKN2C mRNA CTD PMID:15638997 bis(2-chloroethyl) sulfide decreases expression ISO CDKN2C (Homo sapiens) 6480464 Mustard Gas results in decreased expression of CDKN2C mRNA CTD PMID:33491125 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CDKN2C mRNA CTD PMID:22584684 bisphenol A decreases expression ISO Cdkn2c (Mus musculus) 6480464 bisphenol A results in decreased expression of CDKN2C mRNA CTD PMID:21932408 bisphenol A affects expression ISO CDKN2C (Homo sapiens) 6480464 bisphenol A affects the expression of CDKN2C mRNA CTD PMID:30903817 bisphenol A increases expression ISO Cdkn2c (Mus musculus) 6480464 bisphenol A results in increased expression of CDKN2C mRNA CTD PMID:30951980 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CDKN2C mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Estradiol] results in increased expression of CDKN2C mRNA CTD PMID:26496021 bisphenol A decreases expression ISO CDKN2C (Homo sapiens) 6480464 bisphenol A results in decreased expression of CDKN2C mRNA CTD PMID:16474171 and PMID:29275510 Bisphenol B increases expression ISO CDKN2C (Homo sapiens) 6480464 bisphenol B results in increased expression of CDKN2C protein CTD PMID:34186270 bisphenol F increases expression ISO Cdkn2c (Mus musculus) 6480464 bisphenol F results in increased expression of CDKN2C mRNA CTD PMID:30951980 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of CDKN2C mRNA CTD PMID:24136188 butanal decreases expression ISO CDKN2C (Homo sapiens) 6480464 butyraldehyde results in decreased expression of CDKN2C mRNA CTD PMID:26079696 cadmium atom decreases expression ISO CDKN2C (Homo sapiens) 6480464 Cadmium results in decreased expression of CDKN2C mRNA CTD PMID:21120746 calcitriol multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of CDKN2C mRNA CTD PMID:21592394 calcitriol decreases expression ISO CDKN2C (Homo sapiens) 6480464 Calcitriol results in decreased expression of CDKN2C mRNA CTD PMID:21592394 cannabidiol decreases expression ISO CDKN2C (Homo sapiens) 6480464 Cannabidiol results in decreased expression of CDKN2C mRNA CTD PMID:33244087 and PMID:36519830 carbon nanotube decreases expression ISO Cdkn2c (Mus musculus) 6480464 Nanotubes and Carbon results in decreased expression of CDKN2C mRNA CTD PMID:25554681 chloroprene decreases expression ISO Cdkn2c (Mus musculus) 6480464 Chloroprene results in decreased expression of CDKN2C mRNA CTD PMID:23125180 chlorpromazine decreases expression ISO CDKN2C (Homo sapiens) 6480464 Chlorpromazine analog results in decreased expression of CDKN2C mRNA CTD PMID:15924885 choline multiple interactions ISO Cdkn2c (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDKN2C mRNA CTD PMID:20938992 chromium(6+) multiple interactions ISO Cdkn2c (Mus musculus) 6480464 [chromium hexavalent ion co-treated with Benzo(a)pyrene] affects the expression of CDKN2C mRNA CTD PMID:25820237 chrysin decreases expression ISO CDKN2C (Homo sapiens) 6480464 chrysin results in decreased expression of CDKN2C mRNA CTD PMID:18331776 cisplatin increases expression ISO CDKN2C (Homo sapiens) 6480464 Cisplatin results in increased expression of CDKN2C mRNA CTD PMID:27594783 clomipramine affects expression EXP 6480464 Clomipramine affects the expression of CDKN2C mRNA CTD PMID:18355885 cobalt dichloride decreases expression ISO CDKN2C (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of CDKN2C mRNA CTD PMID:19376846 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of CDKN2C mRNA CTD PMID:24386269 copper atom multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of CDKN2C mRNA and [NSC 689534 binds to Copper] which results in decreased expression of CDKN2C mRNA CTD PMID:20971185 and PMID:30911355 copper(0) multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in decreased expression of CDKN2C mRNA and [NSC 689534 binds to Copper] which results in decreased expression of CDKN2C mRNA CTD PMID:20971185 and PMID:30911355 copper(II) sulfate decreases expression ISO CDKN2C (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of CDKN2C mRNA CTD PMID:19549813 coumestrol multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:18310284 and PMID:19167446 coumestrol increases expression ISO CDKN2C (Homo sapiens) 6480464 Coumestrol results in increased expression of CDKN2C mRNA CTD PMID:19167446 CU-O LINKAGE decreases expression ISO CDKN2C (Homo sapiens) 6480464 cupric oxide results in decreased expression of CDKN2C mRNA CTD PMID:22077320 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of CDKN2C mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO Cdkn2c (Mus musculus) 6480464 Cyclosporine results in decreased expression of CDKN2C mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO CDKN2C (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CDKN2C mRNA CTD PMID:20106945 more ... cylindrospermopsin decreases expression ISO CDKN2C (Homo sapiens) 6480464 cylindrospermopsin results in decreased expression of CDKN2C mRNA CTD PMID:23726867 and PMID:30905859 dexamethasone increases expression ISO CDKN2C (Homo sapiens) 6480464 Dexamethasone results in increased expression of CDKN2C mRNA CTD PMID:25047013 diallyl trisulfide decreases expression ISO CDKN2C (Homo sapiens) 6480464 diallyl trisulfide results in decreased expression of CDKN2C mRNA CTD PMID:34995734 diarsenic trioxide increases expression ISO CDKN2C (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of CDKN2C mRNA CTD PMID:17530438 and PMID:20862710 diarsenic trioxide decreases expression ISO CDKN2C (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of CDKN2C mRNA CTD PMID:26705709 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CDKN2C mRNA CTD PMID:21266533 dioxygen multiple interactions ISO Cdkn2c (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CDKN2C mRNA CTD PMID:30529165 divanadium pentaoxide decreases expression ISO CDKN2C (Homo sapiens) 6480464 vanadium pentoxide results in decreased expression of CDKN2C mRNA CTD PMID:17459161 dorsomorphin multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN2C mRNA CTD PMID:27188386 doxorubicin affects response to substance ISO CDKN2C (Homo sapiens) 6480464 CDKN2C protein affects the susceptibility to Doxorubicin CTD PMID:16217747 Enterolactone multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDKN2C mRNA CTD PMID:19167446 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of CDKN2C mRNA CTD PMID:34547370 fluoranthene multiple interactions ISO Cdkn2c (Mus musculus) 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of CDKN2C mRNA CTD PMID:28329830 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CDKN2C mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of CDKN2C mRNA CTD PMID:24793618 folic acid multiple interactions ISO Cdkn2c (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 folic acid decreases expression ISO Cdkn2c (Mus musculus) 6480464 Folic Acid results in decreased expression of CDKN2C mRNA CTD PMID:25629700 genistein decreases expression ISO CDKN2C (Homo sapiens) 6480464 Genistein results in decreased expression of CDKN2C mRNA CTD PMID:16474171 geraniol decreases expression ISO CDKN2C (Homo sapiens) 6480464 geraniol results in decreased expression of CDKN2C mRNA CTD PMID:27683099 GW 4064 increases expression ISO CDKN2C (Homo sapiens) 6480464 GW 4064 results in increased expression of CDKN2C mRNA CTD PMID:31437187 imipramine affects expression EXP 6480464 Imipramine affects the expression of CDKN2C mRNA CTD PMID:18355885 isoflavones decreases expression ISO CDKN2C (Homo sapiens) 6480464 Isoflavones results in decreased expression of CDKN2C mRNA CTD PMID:17374662 kaempferol decreases expression ISO CDKN2C (Homo sapiens) 6480464 kaempferol results in decreased expression of CDKN2C mRNA CTD PMID:18331776 ketoconazole affects expression EXP 6480464 Ketoconazole affects the expression of CDKN2C mRNA CTD PMID:18355885 L-methionine multiple interactions ISO Cdkn2c (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDKN2C mRNA CTD PMID:20938992 lamivudine multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN2C mRNA CTD PMID:15784690 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of CDKN2C mRNA CTD PMID:33862172 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of CDKN2C mRNA CTD PMID:24136188 leflunomide decreases expression ISO CDKN2C (Homo sapiens) 6480464 leflunomide results in decreased expression of CDKN2C mRNA CTD PMID:28988120 lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of CDKN2C mRNA CTD PMID:35283115 linalool increases expression ISO CDKN2C (Homo sapiens) 6480464 linalool results in increased expression of CDKN2C mRNA CTD PMID:26703569 luteolin decreases expression ISO CDKN2C (Homo sapiens) 6480464 Luteolin results in decreased expression of CDKN2C mRNA CTD PMID:18331776 manganese atom decreases expression ISO CDKN2C (Homo sapiens) 6480464 Manganese results in decreased expression of CDKN2C mRNA CTD PMID:17175027 manganese(0) decreases expression ISO CDKN2C (Homo sapiens) 6480464 Manganese results in decreased expression of CDKN2C mRNA CTD PMID:17175027 manganese(II) chloride decreases expression ISO CDKN2C (Homo sapiens) 6480464 manganese chloride results in decreased expression of CDKN2C mRNA CTD PMID:17175027 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of CDKN2C mRNA CTD PMID:22584684 methyl methanesulfonate increases expression ISO CDKN2C (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of CDKN2C mRNA CTD PMID:23649840 methylmercury chloride decreases expression ISO Cdkn2c (Mus musculus) 6480464 methylmercuric chloride results in decreased expression of CDKN2C mRNA CTD PMID:20061341 mono(2-ethylhexyl) phthalate multiple interactions ISO Cdkn2c (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN2C mRNA CTD PMID:31884101 monobenzyl phthalate multiple interactions ISO Cdkn2c (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN2C mRNA CTD PMID:31884101 monoethyl phthalate multiple interactions ISO Cdkn2c (Mus musculus) 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in decreased expression of CDKN2C mRNA CTD PMID:31884101 myricetin increases expression ISO CDKN2C (Homo sapiens) 6480464 myricetin results in increased expression of CDKN2C mRNA CTD PMID:18331776 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO Cdkn2c (Mus musculus) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CDKN2C mRNA CTD PMID:20061341 N-ethyl-N-nitrosourea decreases expression ISO Cdkn2c (Mus musculus) 6480464 Ethylnitrosourea results in decreased expression of CDKN2C protein CTD PMID:28549617 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of CDKN2C mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions ISO Cdkn2c (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDKN2C mRNA and AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of CDKN2C mRNA] CTD PMID:19996281 and PMID:24535843 N-nitrosodiethylamine increases expression ISO Cdkn2c (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of CDKN2C mRNA CTD PMID:18282651 and PMID:24535843 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CDKN2C mRNA CTD PMID:20360939 N-nitrosodiethylamine decreases expression ISO Cdkn2c (Mus musculus) 6480464 Diethylnitrosamine results in decreased expression of CDKN2C mRNA CTD PMID:19996281 N-Nitrosopyrrolidine decreases expression ISO CDKN2C (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in decreased expression of CDKN2C mRNA CTD PMID:32234424 nickel atom decreases expression ISO CDKN2C (Homo sapiens) 6480464 Nickel results in decreased expression of CDKN2C mRNA CTD PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of CDKN2C mRNA CTD PMID:22546817 nimesulide multiple interactions ISO CDKN2C (Homo sapiens) 6480464 nimesulide inhibits the reaction [PTGS2 results in decreased expression of CDKN2C mRNA] CTD PMID:11961048 oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of CDKN2C mRNA CTD PMID:25729387 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CDKN2C mRNA CTD PMID:25729387 paclitaxel affects response to substance ISO CDKN2C (Homo sapiens) 6480464 CDKN2C protein affects the susceptibility to Paclitaxel CTD PMID:16217747 palbociclib multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [CDKN2A protein co-treated with CDKN2C protein] affects the susceptibility to palbociclib CTD PMID:20534551 paracetamol affects expression ISO Cdkn2c (Mus musculus) 6480464 Acetaminophen affects the expression of CDKN2C mRNA CTD PMID:17562736 paracetamol decreases expression ISO CDKN2C (Homo sapiens) 6480464 Acetaminophen results in decreased expression of CDKN2C mRNA CTD PMID:29067470 paraquat increases expression ISO Cdkn2c (Mus musculus) 6480464 Paraquat results in increased expression of CDKN2C mRNA CTD PMID:28012437 parathion decreases expression ISO CDKN2C (Homo sapiens) 6480464 Parathion results in decreased expression of CDKN2C mRNA CTD PMID:17622325 pentanal decreases expression ISO CDKN2C (Homo sapiens) 6480464 pentanal results in decreased expression of CDKN2C mRNA CTD PMID:26079696 perfluorohexanesulfonic acid increases expression ISO CDKN2C (Homo sapiens) 6480464 perfluorohexanesulfonic acid results in increased expression of CDKN2C mRNA CTD PMID:25812627 perfluorononanoic acid decreases expression ISO CDKN2C (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of CDKN2C mRNA CTD PMID:25812627 and PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO Cdkn2c (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CDKN2C mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of CDKN2C mRNA CTD PMID:36331819 perfluorooctane-1-sulfonic acid increases expression ISO CDKN2C (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of CDKN2C mRNA CTD PMID:25812627 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of CDKN2C mRNA CTD PMID:20360939 phenobarbital multiple interactions ISO Cdkn2c (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDKN2C mRNA and NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CDKN2C mRNA] CTD PMID:19482888 and PMID:24535843 phenobarbital affects expression ISO Cdkn2c (Mus musculus) 6480464 Phenobarbital affects the expression of CDKN2C mRNA CTD PMID:23091169 phenobarbital increases expression ISO Cdkn2c (Mus musculus) 6480464 Phenobarbital results in increased expression of CDKN2C mRNA CTD PMID:19270015 more ... phorbol 13-acetate 12-myristate multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CDKN2C mRNA CTD PMID:16979875 phosgene affects expression ISO Cdkn2c (Mus musculus) 6480464 Phosgene affects the expression of CDKN2C mRNA CTD PMID:16300373 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CDKN2C mRNA CTD PMID:22484513 potassium chromate decreases expression ISO CDKN2C (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of CDKN2C mRNA CTD PMID:22714537 progesterone increases expression ISO CDKN2C (Homo sapiens) 6480464 Progesterone results in increased expression of CDKN2C mRNA CTD PMID:18070364 propanal decreases expression ISO CDKN2C (Homo sapiens) 6480464 propionaldehyde results in decreased expression of CDKN2C mRNA CTD PMID:26079696 quercetin increases expression ISO CDKN2C (Homo sapiens) 6480464 Quercetin results in increased expression of CDKN2C mRNA CTD PMID:18331776 quercetin decreases expression ISO CDKN2C (Homo sapiens) 6480464 Quercetin results in decreased expression of CDKN2C mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO CDKN2C (Homo sapiens) 6480464 Lactic Acid results in decreased expression of CDKN2C mRNA CTD PMID:30851411 resveratrol decreases expression ISO Cdkn2c (Mus musculus) 6480464 resveratrol results in decreased expression of CDKN2C protein CTD PMID:23525482 SB 431542 multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN2C mRNA CTD PMID:27188386 silver atom affects expression ISO Cdkn2c (Mus musculus) 6480464 Silver affects the expression of CDKN2C mRNA CTD PMID:27131904 silver(0) affects expression ISO Cdkn2c (Mus musculus) 6480464 Silver affects the expression of CDKN2C mRNA CTD PMID:27131904 silver(1+) nitrate affects expression ISO CDKN2C (Homo sapiens) 6480464 Silver Nitrate analog affects the expression of CDKN2C mRNA CTD PMID:22831968 sodium arsenite increases expression ISO CDKN2C (Homo sapiens) 6480464 sodium arsenite results in increased expression of CDKN2C mRNA CTD PMID:28595984 and PMID:34032870 Soman increases expression EXP 6480464 Soman results in increased expression of CDKN2C mRNA CTD PMID:19281266 sterigmatocystin increases expression EXP 6480464 Sterigmatocystin results in increased expression of CDKN2C mRNA CTD PMID:34126181 sunitinib decreases expression ISO CDKN2C (Homo sapiens) 6480464 Sunitinib results in decreased expression of CDKN2C mRNA CTD PMID:31533062 tert-butyl hydroperoxide decreases expression ISO CDKN2C (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of CDKN2C mRNA CTD PMID:15336504 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of CDKN2C mRNA CTD PMID:21515302 testosterone decreases expression ISO CDKN2C (Homo sapiens) 6480464 Testosterone results in decreased expression of CDKN2C mRNA CTD PMID:21592394 testosterone decreases expression ISO Cdkn2c (Mus musculus) 6480464 Testosterone deficiency results in decreased expression of CDKN2C mRNA CTD PMID:33848595 testosterone multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of CDKN2C mRNA CTD PMID:21592394 tetrachloromethane increases expression ISO Cdkn2c (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of CDKN2C mRNA CTD PMID:27339419 tetrachloromethane affects expression ISO Cdkn2c (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of CDKN2C mRNA CTD PMID:31919559 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CDKN2C mRNA CTD PMID:34492290 titanium dioxide increases expression ISO Cdkn2c (Mus musculus) 6480464 titanium dioxide results in increased expression of CDKN2C mRNA CTD PMID:23557971 titanium dioxide multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [Vitallium analog binds to titanium dioxide] which results in decreased expression of CDKN2C mRNA CTD PMID:23825117 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of CDKN2C mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CDKN2C mRNA CTD PMID:25729387 Tributyltin oxide decreases expression ISO Cdkn2c (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in decreased expression of CDKN2C mRNA CTD PMID:18958704 Tributyltin oxide decreases expression EXP 6480464 bis(tri-n-butyltin)oxide results in decreased expression of CDKN2C mRNA CTD PMID:17553608 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CDKN2C mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO Cdkn2c (Mus musculus) 6480464 trimellitic anhydride results in increased expression of CDKN2C mRNA CTD PMID:19042947 Triptolide increases expression EXP 6480464 triptolide results in increased expression of CDKN2C mRNA CTD PMID:23639586 troglitazone decreases expression ISO CDKN2C (Homo sapiens) 6480464 troglitazone results in decreased expression of CDKN2C mRNA CTD PMID:19140230 troglitazone increases expression ISO CDKN2C (Homo sapiens) 6480464 troglitazone results in increased expression of CDKN2C protein CTD PMID:11343236 troglitazone decreases expression ISO Cdkn2c (Mus musculus) 6480464 troglitazone results in decreased expression of CDKN2C mRNA CTD PMID:12732648 trovafloxacin decreases expression ISO Cdkn2c (Mus musculus) 6480464 trovafloxacin results in decreased expression of CDKN2C mRNA CTD PMID:35537566 valproic acid affects expression ISO CDKN2C (Homo sapiens) 6480464 Valproic Acid affects the expression of CDKN2C mRNA CTD PMID:25979313 valproic acid increases expression ISO CDKN2C (Homo sapiens) 6480464 Valproic Acid results in increased expression of CDKN2C mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDKN2C mRNA CTD PMID:27188386 vincaleukoblastine affects response to substance ISO CDKN2C (Homo sapiens) 6480464 CDKN2C protein affects the susceptibility to Vinblastine CTD PMID:16217747 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CDKN2C mRNA CTD PMID:23869203 vincristine decreases expression ISO CDKN2C (Homo sapiens) 6480464 Vincristine results in decreased expression of CDKN2C mRNA CTD PMID:23649840 zidovudine multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [Zidovudine co-treated with Lamivudine] results in decreased expression of CDKN2C mRNA CTD PMID:15784690 zinc atom multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CDKN2C mRNA CTD PMID:16979875 zinc(0) multiple interactions ISO CDKN2C (Homo sapiens) 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CDKN2C mRNA CTD PMID:16979875